arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 4/2011 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    GLOSSARY

    Per protocol analysis

    SPOT ON

    Surrogate endpoints to evaluate benefit in oncology

    THERAPY FROM A CRITICAL VIEWPOINT

    POET-COPD: tiotropium superior to salmeterol

    a-t READER'S QUESTIONS AND COMMENTS

    SHIFT study: reevaluation of ivabradine necessary?

    UCB: the same with differences

    IN BRIEF

    Diuretic strategies for decompensated heart failure

    Long-acting risperidone in schizophrenia

    Lavender oil (LASEA) and the German Medical Products Advertising Act

    Medical journals: influence of funding sources on the content

    Cave: vfa brochure - ideal pharmaceutical world for teenagers

    CURRENT ADR NETWORK REPORT

    Angioedema due to saxagliptin (ONGLYZA)?

    Nightmares, depression with dronedarone (MULTAQ)
    free

    SIDE EFFECTS

    Increased cardiovascular mortality with olmesartan

    e a-t IN THE INTERNET

    Lavender oil (LASEA): Spitzner comments on the a-t article

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles